The ability of GSK-3β to contribute to the phosphorylation of tau and Aβ production provides a link between the two pathologies and suggests a key role for GSK-3β in the pathogenesis of Alzheimer’s disease, where zinc ions may be involved through activating GSK-3β. This evidence concerns the gene MAPT and Alzheimer disease.